Cognyte Software Ltd. (CGNT) — Earnings Call X-Ray
Our AI read all 26 of CGNT's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
C+
Q4 2025
Calls Analyzed
26
2016–2025
Avg Candor
6.3/9
evasion 2.5/9
Call-by-call analysis
🔒 Q1 2026 earnings call
2025-06-11
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q1 2026 call grade is ready
The full 37-point AI read of CGNT's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
C+
Q4 2025 earnings call
2025-04-02
move ±15.4%
Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics.
Guidance: maintainedDemand: stableMargins: expandingBacklog: shrinkingPricing: stableHeadcount: growingCapex: flat 3 analysts · 6 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growingCFO dominates
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
A
Q3 2025 earnings call
2024-12-11
move ±17.7%
Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.
Guidance: raisedDemand: acceleratingMargins: expandingBacklog: stablePricing: stable 2 analysts · 4 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
A
Q2 2025 earnings call
2024-09-10
move ±11.7%
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.
Guidance: raisedDemand: stableMargins: expandingBacklog: stablePricing: stable 1 analysts · 2 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
B+
Q1 2025 earnings call
2024-06-18
move ±10%
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.
Guidance: raisedDemand: stableMargins: expandingBacklog: shrinking 3 analysts · 5 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO
B+
Q4 2024 earnings call
2024-04-09
move ±14.5%
Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.
Guidance: maintainedDemand: stableMargins: expandingBacklog: growingPricing: stableCapex: increasing 3 analysts · 7 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
B+
Q3 2024 earnings call
2023-12-13
move ±16.3%
Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics.
Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: stable 2 analysts · 5 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
A
Q2 2024 earnings call
2023-09-12
move ±17.1%
Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.
Guidance: raisedDemand: acceleratingMargins: expandingBacklog: stablePricing: stable 1 analysts · 3 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q1 2024 |
2023-06-15 |
B+ |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q4 2022 |
2023-04-11 |
B |
raised | stable | expanding |
6/9 |
3/9 |
| Q3 2023 |
2022-12-20 |
B |
raised | mixed | contracting |
7/9 |
2/9 |
| Q2 2023 |
2022-09-28 |
F |
withdrawn | slowing | unclear |
7/9 |
4/9 |
| Q1 2023 |
2022-06-28 |
F |
withdrawn | slowing | contracting |
7/9 |
4/9 |
| Q4 2022 |
2022-04-05 |
F |
withdrawn | slowing | expanding |
7/9 |
3/9 |
| Q3 2021 |
2021-12-21 |
F |
lowered | stable | expanding |
6/9 |
5/9 |
| Q2 2022 |
2021-09-20 |
B+ |
raised | stable | expanding |
6/9 |
2/9 |
| Q1 2022 |
2021-06-22 |
B |
maintained | stable | expanding |
6/9 |
4/9 |
| Q4 2020 |
2021-05-01 |
B+ |
maintained | accelerating | expanding |
6/9 |
2/9 |
| Q3 2017 |
2017-11-12 |
B |
maintained | stable | expanding |
7/9 |
2/9 |
| Q2 2017 |
2017-08-01 |
B |
none | accelerating | contracting |
7/9 |
2/9 |
| Q1 2017 |
2017-05-02 |
C+ |
none | mixed | contracting |
7/9 |
2/9 |
| Q4 2016 |
2017-03-09 |
D |
withdrawn | stable | expanding |
7/9 |
3/9 |
| Q3 2016 |
2016-11-08 |
C+ |
none | accelerating | expanding |
7/9 |
2/9 |
| Q2 2016 |
2016-08-02 |
C |
maintained | accelerating | expanding |
6/9 |
2/9 |
| Q1 2016 |
2016-05-07 |
C+ |
maintained | accelerating | expanding |
6/9 |
2/9 |
| Q4 2015 |
2016-03-03 |
F |
withdrawn | accelerating | contracting |
6/9 |
3/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of CGNT's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
D
Q4 2016 earnings call
2017-03-09
18 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← CGJTF All “C” companies
CGNX →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.